ArticleClinical neuropsychiatry2025
Development and Preliminary Validation of a Pakistani Neuropsychological Test Assessment Battery-Pantab.
Article in Clinical neuropsychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: the main objective of present research project was to develop and validate a neuropsychological test assessment battery to evaluate the neuropsychological profiles of healthy and clinical populations from Pakistani. Method: the battery was developed in two languages, URDU and non-native English, to assess neuropsychological functioning of illiterate to highly literate Urdu Speaking and bilingual Pakistani populations. It was named as Pakistani Neuropsychological Test Assessment Battery (PANATB). The PANTAB assessed neuropsychological functioning from six domains namely orientation, attention and concentration, language, visuo-spatial & perceptual ability, memory, and executive functions. It included items most relevant to Pakistani norms and culture. Its administration time is 35 to 40 minutes. The project was completed in two phases of development and validation. Validation was done in two studies. Results: the first study evaluated and established the retest reliability and concurrent validity on a sample of adolescents and adults (n1=216). Age and educational differences were also observed in performance. Clinical and convergent validities were established in the second study (n=122) by comparing the performance of two clinical subgroups of patients with traumatic brain injury and stroke with healthy participants. Conclusions: the PANTAB is a valid measure of neuropsychological assessment and is sensitive to identifying cognitive impairment associated with clinical conditions and aging. It may fulfill the need for brief, reliable, and objective evaluation of a broad range of neurocognitive functions in the Pakistani clinical and non-clinical populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.